Skip to content

Clinical trials

Phase 2 Carcinoma, Hepatocellular trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Country / region: France Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20052
20062
20081
20094
20103
20116
20121
20132
20161
20183
20191
20201
20215
20224
20234
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated8
Recruiting6
Active, not recruiting5
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris5
Bayer5
University Hospital, Montpellier3
Boston Scientific Corporation2
Bristol-Myers Squibb2
Center Eugene Marquis2
AbbVie1
Astellas Pharma Inc1
BeiGene1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular47
Liver Neoplasms11
Neoplasms4
Liver Diseases3
Ovarian Neoplasms3
Adenocarcinoma2
Carcinoma2
Cholangiocarcinoma2
Colorectal Neoplasms2
Digestive System Neoplasms2

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.